KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,901,000 | +29.5% | 2,372,234 | +17.3% | 0.00% | +50.0% |
| Q3 2016 | $10,735,000 | -14.0% | 2,021,682 | +7.3% | 0.00% | -33.3% |
| Q2 2016 | $12,478,000 | +7.7% | 1,884,848 | -24.1% | 0.00% | 0.0% |
| Q1 2016 | $11,590,000 | -10.7% | 2,481,833 | -3.4% | 0.00% | 0.0% |
| Q4 2015 | $12,976,000 | +49.8% | 2,569,538 | +4.4% | 0.00% | +50.0% |
| Q3 2015 | $8,660,000 | -65.1% | 2,460,288 | -1.0% | 0.00% | -66.7% |
| Q2 2015 | $24,796,000 | -25.4% | 2,484,529 | -4.8% | 0.01% | -25.0% |
| Q1 2015 | $33,221,000 | +0.6% | 2,609,640 | +11.8% | 0.01% | 0.0% |
| Q4 2014 | $33,025,000 | +20.8% | 2,333,888 | +17.4% | 0.01% | 0.0% |
| Q3 2014 | $27,329,000 | -13.2% | 1,987,560 | -2.9% | 0.01% | -11.1% |
| Q2 2014 | $31,489,000 | -26.1% | 2,047,374 | -18.2% | 0.01% | -30.8% |
| Q1 2014 | $42,630,000 | +48.2% | 2,501,741 | +12.6% | 0.01% | +44.4% |
| Q4 2013 | $28,766,000 | +23.5% | 2,221,305 | -3.8% | 0.01% | +12.5% |
| Q3 2013 | $23,295,000 | +53.0% | 2,308,736 | +13.3% | 0.01% | +33.3% |
| Q2 2013 | $15,226,000 | – | 2,038,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |